Logo image
Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus
Journal article   Open access   Peer reviewed

Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus

Amr H. Sawalha, Susan Manzi and Division of Rheumatology, Department of Pediatrics, Children’s Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
European journal of rheumatology, v 7(Suppl 2), pp S117-S120
01 Aug 2020
PMID: 32352359
url
https://doi.org/10.5152/eurjrheum.2020.20055View
Published, Version of Record (VoR)CC BY-NC V4.0 Open

Abstract

Short Communication
Systemic lupus erythematosus is a chronic remitting-relapsing autoimmune disease that affects multiple organ systems. In this article we discuss aspects in the management of lupus patients that are particularly relevant during the current SARS-CoV-2 pandemic. We speculate that lupus patients might be more susceptible for a more severe COVID-19 disease course and emphasize the importance of maintaining remission in lupus patients. We discuss the critical role hydroxychloroquine plays in the management of lupus patients and suggest considering the psychosocial implications of the current pandemic on lupus care.

Metrics

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Rheumatology
Logo image